Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure

Albany Medical College

Status: Terminated

Conditions: Patent Ductus Arteriosus

Treatments: Device: near infrared spectroscopy

Study type: Observational

Funder types: Other

Identifiers

NCT03026192

4585

Details and patient eligibility

About

Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.

Enrollment: 4 patients

Sex: All

Ages: 1 minute to 1 week old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• preterm infants less than 32 weeks gestation

Exclusion criteria

• infection, congenital heart disease, syndromic anomalies, and perinatal asphyxia.

Trial design

4 participants in 2 patient groups

no PDA

Description:

These are infants who do not have a patent ductus arteriosus (PDA) as determine by echocardiography

Treatment:

Device: near infrared spectroscopy

hsPDA

Description:

These are infants who have a hemodynamically significant PDA (hsPDA) as determined by echocardiography

Treatment:

Device: near infrared spectroscopy